Market Research Logo

Morocco Pharmaceuticals and Healthcare Report Q2 2016

Morocco Pharmaceuticals and Healthcare Report Q2 2016

BMI View: We hold an optimistic outlook for the Moroccan pharmaceutical market despite the economicslowdown over 2016. We expect the government's increasing efforts to improve healthcare coveragecoupled with the country's growing non-communicable disease burden will drive the demand for medicinesin long-term. A major downside risk to our forecast is the uncertainty surrounding drug prices as a result ofprice cuts and increased taxation on medicines in recent years, which will negatively impact theattractiveness of the market to multinational drugmakers.

Headline Expenditure Projections

Pharmaceuticals: MAD13.39bn (USD1.40bn) in 2015 to MAD14.34bn (USD1.46bn) in 2016; +7.1% inlocal currency terms and +4.0% in US dollar terms. Forecast inline with last quarter.

Healthcare: MAD59.15bn (USD6.19bn) in 2015 to MAD62.83bn (USD6.38bn) in 2016; +6.2% in localcurrency terms and +3.1% in US dollar terms. Forecast revised downwards from last quarter.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Morocco 2014
2020)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Morocco 2012
2020)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Morocco 2012
2020)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Morocco 2012
2020)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Morocco 2012
2020)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Morocco 2012
2020)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Morocco 2012
2020)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Morocco 2012
2020)
OTC Drug Market Forecast
Table: Over
TheCounter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Morocco 20122020)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Morocco 2014
2020)
Table: Pharmaceutical Trade Data And Forecasts local currency (Morocco 2014
2020)
Pharmaceuticals & Healthcare Risk/Reward Index
Middle East and Africa Risk/Reward Index Q2 2016
Morocco Risk/ Reward Index
Rewards
Risks
Regulatory Review
Intellectual Property Regime
Pricing Regime
Reimbursement Regime
Market Overview
Epidemiology
Healthcare Sector
Table: Healthcare Resources (Morocco 2010
2015)
Table: Healthcare Personnel (Morocco 2010
2015)
Table: Healthcare Activity (Morocco 2010
2015)
Healthcare Insurance
Recent Health Insurance Developments
Research & Development
Clinical Trials
Competitive Landscape
Pharmaceutical Industry
Table: Morocco's Select Pharmaceutical Industry Indicators
Table: Members Of MIS, 2011
Table: Members Of AMIP, 2011
Domestic Pharmaceutical sector
Foreign Pharmaceutical Companies
Table: Multinational Market Activity
Pharmaceutical Wholesale
Pharmaceutical Retail
Company Profile
GlaxoSmithKline
Laprophan
Pfizer
Sanofi
Sothema
Demographic Forecast
Demographic Outlook
Table: Population Headline Indicators (Morocco 1990
2025)
Table: Key Population Ratios (Morocco 1990
2025)
Table: Urban/Rural Population & Life Expectancy (Morocco 1990
2025)
Table: Population By Age Group (Morocco 1990
2025)
Table: Population By Age Group % (Morocco 1990
2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report